These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 18801465)

  • 1. Immunological aspects of chronic fatigue syndrome.
    Lorusso L; Mikhaylova SV; Capelli E; Ferrari D; Ngonga GK; Ricevuti G
    Autoimmun Rev; 2009 Feb; 8(4):287-91. PubMed ID: 18801465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW; van Driel ML; Staines DR; Ashton KJ; Hardcastle SL; Keane J; Tajouri L; Peterson D; Ramos SB; Marshall-Gradisnik SM
    J Transl Med; 2012 May; 10():88. PubMed ID: 22571715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW; van Driel ML; Staines DR; Ashton KJ; Ramos SB; Keane J; Klimas NG; Marshall-Gradisnik SM
    J Transl Med; 2011 May; 9():81. PubMed ID: 21619669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
    Front Immunol; 2019; 10():796. PubMed ID: 31057538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
    Maes M; Bosmans E; Kubera M
    Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic abnormalities associated with chronic fatigue syndrome.
    Barker E; Fujimura SF; Fadem MB; Landay AL; Levy JA
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S136-41. PubMed ID: 8148441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S
    BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological abnormalities in patients with chronic fatigue syndrome.
    Tirelli U; Marotta G; Improta S; Pinto A
    Scand J Immunol; 1994 Dec; 40(6):601-8. PubMed ID: 7997849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.
    Curriu M; Carrillo J; Massanella M; Rigau J; Alegre J; Puig J; Garcia-Quintana AM; Castro-Marrero J; Negredo E; Clotet B; Cabrera C; Blanco J
    J Transl Med; 2013 Mar; 11():68. PubMed ID: 23514202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Rivas JL; Palencia T; Fernández G; García M
    Front Immunol; 2018; 9():1028. PubMed ID: 29867995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Fatty Acid Oxidation in Lymphocyte Populations of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Maya J; Leddy SM; Gottschalk CG; Peterson DL; Hanson MR
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Balinas C; Cabanas H; Staines D; Marshall-Gradisnik S
    J Transl Med; 2019 Dec; 17(1):401. PubMed ID: 31796045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome.
    Eaton-Fitch N; du Preez S; Cabanas H; Staines D; Marshall-Gradisnik S
    Syst Rev; 2019 Nov; 8(1):279. PubMed ID: 31727160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic fatigue syndrome and the immune system: Where are we now?
    Mensah FKF; Bansal AS; Ford B; Cambridge G
    Neurophysiol Clin; 2017 Apr; 47(2):131-138. PubMed ID: 28410877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S
    Front Immunol; 2019; 10():2545. PubMed ID: 31736966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.
    Mensah F; Bansal A; Berkovitz S; Sharma A; Reddy V; Leandro MJ; Cambridge G
    Clin Exp Immunol; 2016 May; 184(2):237-47. PubMed ID: 26646713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
    Maes M; Twisk FN; Kubera M; Ringel K
    J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.